Sargent Bickham Lagudis’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-85
| Closed | -$5K | – | 977 |
|
|
2021
Q2 | $5K | Hold |
85
| – | – | ﹤0.01% | 803 |
|
|
2021
Q1 | $6K | Hold |
85
| – | – | ﹤0.01% | 777 |
|
|
2020
Q4 | $7K | Hold |
85
| – | – | ﹤0.01% | 704 |
|
|
2020
Q3 | $5K | Hold |
85
| – | – | ﹤0.01% | 665 |
|
|
2020
Q2 | $4K | Hold |
85
| – | – | ﹤0.01% | 667 |
|
|
2020
Q1 | $2K | Hold |
85
| – | – | ﹤0.01% | 714 |
|
|
2019
Q4 | $6K | Hold |
85
| – | – | ﹤0.01% | 675 |
|
|
2019
Q3 | $12K | Hold |
85
| – | – | ﹤0.01% | 542 |
|
|
2019
Q2 | $16K | Hold |
85
| – | – | ﹤0.01% | 535 |
|
|
2019
Q1 | $14K | Hold |
85
| – | – | ﹤0.01% | 567 |
|
|
2018
Q4 | $8K | Hold |
85
| – | – | ﹤0.01% | 613 |
|
|
2018
Q3 | $12K | Hold |
85
| – | – | ﹤0.01% | 587 |
|
|
2018
Q2 | $13K | Hold |
85
| – | – | ﹤0.01% | 548 |
|
|
2018
Q1 | $14K | Hold |
85
| – | – | ﹤0.01% | 532 |
|
|
2017
Q4 | $14K | Hold |
85
| – | – | ﹤0.01% | 554 |
|
|
2017
Q3 | $5K | Hold |
85
| – | – | ﹤0.01% | 698 |
|
|
2017
Q2 | $7K | Hold |
85
| – | – | ﹤0.01% | 626 |
|
|
2017
Q1 | $6K | Hold |
85
| – | – | ﹤0.01% | 646 |
|
|
2016
Q4 | $4K | Hold |
85
| – | – | ﹤0.01% | 641 |
|
|
2016
Q3 | $4 | Hold |
85
| – | – | ﹤0.01% | 661 |
|
|
2016
Q2 | $3K | Hold |
85
| – | – | ﹤0.01% | 654 |
|
|
2016
Q1 | $3K | Buy |
+85
| New | +$3K | ﹤0.01% | 669 |
|